Introduction Data from the "Trattamento Ormonale nello Scompenso CArdiaco" (T.O.S.CA) registry showed that heart failure (HF) represents a complex clinical syndrome with different hormonal alterations. Renal failure represents a frequent complication in HF. We evaluated the relationship between renal function and insuline-like growth factor-1 (IGF-1) deficiency and its impact on cardiovascular mortality (CVM) in patients enrolled in the T.O.S.CA. registry. Methods At the enrolment, all subjects underwent chemistry examinations, including circulating hormones and cardiovascular functional tests. COX regression analysis was used to evaluate factors related to CVM during the follow-up period in all populations, in high-risk patients and in the young-adult population. Also, we evaluate the effects of renal function on the CVM. Results 337 patients (41 deceased) were analyzed. CVM was related to severe renal dysfunction (HR stages IV-V = 4.86), high-risk conditions (HR 2.25), serum IGF-1 (HR 0.42), and HF etiology (HR 5.85 and HR 1.63 for valvular and ischemic etiology, respectively). In high-risk patients, CVM was related to IGF-1 levels, severe renal dysfunction and valvular etiology, whereas in young patients CMV was related to the high-risk pattern and serum IGF-1 levels. Conclusions Our study showed the clinical and prognostic utility of the IGF-1 assay in patients with HF.
Insulin-like growth factor-1 (IGF-1) as predictor of cardiovascular mortality in heart failure patients: data from the T.O.S.CA. registry / De Giorgi, Alfredo; Marra, Alberto Maria; Iacoviello, Massimo; Triggiani, Vincenzo; Rengo, Giuseppe; Cacciatore, Francesco; Maiello, Ciro; Limongelli, Giuseppe; Masarone, Daniele; Perticone, Francesco; Filardi, Pasquale Perrone; Paolillo, Stefania; Mancini, Antonio; Volterrani, Maurizio; Vriz, Olga; Castello, Roberto; Passantino, Andrea; Campo, Michela; Modesti, Pietro Amedeo; Salzano, Andrea; D’Assante, Roberta; Arcopinto, Michele; Raparelli, Valeria; Fabbian, Fabio; Sciacqua, Angela; Colao, Annamaria; Suzuki, Toru; Bossone, Eduardo; Cittadini, Antonio; Cittadini, A.; Arcopintosalzano, M. A.; Saccà, L.; Monti, M. G.; Napoli, R.; Matarazzo, M.; Stagnaro, F. M.; Schiavo, A.; Valente, P.; Bossone, E.; Ferrara, F.; Russo, V.; Malinconico, M.; Citro, R.; Guastalamacchia, E.; Iacoviello, M.; Leone, M.; Triggiani, V.; Cacciatore, F.; Maiello, C.; Amarelli, C.; Mattucci, I.; Limongelli, G.; Masarone, D.; Calabrò, P.; Calabrò, R.; D’Andrea, A.; Maddaloni, V.; Pacileo, G.; Scarafile, R.; Perticone, F.; Belfiore, A.; Sci-acqua, A.; Cimellaro, A.; Filardi, P. Perrone; Casaretti, L.; Paolillo, S.; Gargiulo, P.; Mancini, A.; Favuzzi, A. M. R.; Di Segni, C.; Bruno, C.; Vergani, E.; Vriz, O.; Castello, R.; Frigo, A.; Campo, M.; Sorrentino, M. R.; Modesti, P. A.; Malandrino, D.; Manfredini, R.; De Giorgi, A.; Fabbian, F.; Puzzo, A.; Ragusa, L.; Caliendo, L.; Carbone, L.; Frigiola, A.; Generali, T.; Giacomazzi, F.; De Vincentiis, C.; Ballotta, A.; Garofalo, P.; Malizia, G.; Suzuki, T.; Heaney, L. M.; Bruzzese, D.; Null, Null. - In: INTERNAL AND EMERGENCY MEDICINE. - ISSN 1828-0447. - 17:6(2022), pp. 1651-1660. [10.1007/s11739-022-02980-4]
Insulin-like growth factor-1 (IGF-1) as predictor of cardiovascular mortality in heart failure patients: data from the T.O.S.CA. registry
Raparelli, Valeria;
2022
Abstract
Introduction Data from the "Trattamento Ormonale nello Scompenso CArdiaco" (T.O.S.CA) registry showed that heart failure (HF) represents a complex clinical syndrome with different hormonal alterations. Renal failure represents a frequent complication in HF. We evaluated the relationship between renal function and insuline-like growth factor-1 (IGF-1) deficiency and its impact on cardiovascular mortality (CVM) in patients enrolled in the T.O.S.CA. registry. Methods At the enrolment, all subjects underwent chemistry examinations, including circulating hormones and cardiovascular functional tests. COX regression analysis was used to evaluate factors related to CVM during the follow-up period in all populations, in high-risk patients and in the young-adult population. Also, we evaluate the effects of renal function on the CVM. Results 337 patients (41 deceased) were analyzed. CVM was related to severe renal dysfunction (HR stages IV-V = 4.86), high-risk conditions (HR 2.25), serum IGF-1 (HR 0.42), and HF etiology (HR 5.85 and HR 1.63 for valvular and ischemic etiology, respectively). In high-risk patients, CVM was related to IGF-1 levels, severe renal dysfunction and valvular etiology, whereas in young patients CMV was related to the high-risk pattern and serum IGF-1 levels. Conclusions Our study showed the clinical and prognostic utility of the IGF-1 assay in patients with HF.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
